Los Angeles Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-132,606
Closed -$743K 1328
2024
Q2
$743K Sell
132,606
-59,126
-31% -$331K ﹤0.01% 748
2024
Q1
$1M Buy
191,732
+100,470
+110% +$526K ﹤0.01% 687
2023
Q4
$477K Buy
91,262
+36,982
+68% +$193K ﹤0.01% 885
2023
Q3
$856K Sell
54,280
-15,404
-22% -$243K ﹤0.01% 689
2023
Q2
$1.35M Sell
69,684
-4,931
-7% -$95.9K 0.01% 582
2023
Q1
$2.12M Buy
74,615
+32,339
+76% +$917K 0.01% 485
2022
Q4
$1.24M Buy
+42,276
New +$1.24M 0.01% 645
2022
Q3
Sell
-34,358
Closed -$1.53M 1408
2022
Q2
$1.53M Sell
34,358
-9,036
-21% -$402K 0.01% 597
2022
Q1
$2.15M Buy
43,394
+4,476
+12% +$222K 0.01% 509
2021
Q4
$1.98M Sell
38,918
-21
-0.1% -$1.07K 0.01% 517
2021
Q3
$2.17M Sell
38,939
-3,770
-9% -$210K 0.01% 515
2021
Q2
$1.83M Buy
42,709
+25,050
+142% +$1.07M 0.01% 609
2021
Q1
$737K Sell
17,659
-2,115
-11% -$88.3K ﹤0.01% 1048
2020
Q4
$921K Sell
19,774
-18,375
-48% -$856K ﹤0.01% 976
2020
Q3
$1.62M Sell
38,149
-7,637
-17% -$325K 0.01% 635
2020
Q2
$2.2M Buy
45,786
+13,681
+43% +$656K 0.01% 591
2020
Q1
$1.48M Buy
32,105
+10,910
+51% +$502K 0.01% 615
2019
Q4
$1.27M Hold
21,195
0.01% 765
2019
Q3
$1.2M Buy
21,195
+6,530
+45% +$369K 0.01% 764
2019
Q2
$817K Hold
14,665
﹤0.01% 904
2019
Q1
$740K Hold
14,665
﹤0.01% 962
2018
Q4
$591K Buy
14,665
+2,115
+17% +$85.2K ﹤0.01% 916
2018
Q3
$870K Buy
+12,550
New +$870K ﹤0.01% 918